June 20204- AbbVie launched the AbbVie Migraine Career Catalyst Award, a first-of-its-kind contest designed to support the career, workplace, and professional development aspirations of people living with migraine. With more than 113 million workdays lost in the U.S. each year to the disease and its symptoms, migraine can have a major impact on the workplace. Twenty contest entrants will win up to $2,500 that they can decide to use toward career support, including career counseling, professional development programs, and networking opportunities.
“With the launch of the AbbVie Migraine Career Catalyst Award, we’re taking our commitment to the migraine community beyond the medicine and hoping to empower migraine patients to pursue their career goals with confidence,” said Jag Dosanjh, senior vice president, AbbVie, and president, neuroscience and eye care. “While migraine has a significant impact on many areas of life, including work, we are proud to support people living with the disease as they strive for migraine freedom.”
Also Read: Game-Changing Cancer Treatment: AbbVie and Umoja Biopharma Partner Up
“Common migraine symptoms – including extra sensitivity to lights, sounds and smells, nausea, intense pain, difficulty thinking clearly and more – can make it difficult or impossible to work,” said Dr. Dawn Buse, clinical professor of neurology at Albert Einstein College of Medicine in New York City, fellow of the American Headache Society (AHS), and board member of the Headache Cooperative of the Pacific (HCOP). “With the recent progress in migraine management, people living with migraine have more options than ever before to live their lives the way they want to, both in the workplace and beyond. This contest helps to support that objective.”
Visit the contest website at www.migrainecareercatalyst.com and follow the instructions to submit either (a) an essay of up to 3,000 characters, (b) a video of up to three minutes, or (c) an audio clip of up to three minutes. Describe your experience with migraine, your career goals, and how this award might help your career.
Furthermore, The submission period for the AbbVie Migraine Career Catalyst Award is now open and will close at 12:00 p.m. Eastern Time (ET) on Sept. 3, 2024. The winners will be announced on or about November 15, 2024. Please see full contest Official Rules athttp://www.migrainecareercatalyst.com/.
